Distinctive immunomodulatory and inflammatory properties of the Escherichia coli type II heat-labile enterotoxin LT-IIa and its B pentamer following intradermal administration.
about
Immune Adjuvant Effect of Molecularly-defined Toll-Like Receptor LigandsIntradermal administration of the Type II heat-labile enterotoxins LT-IIb and LT-IIc of enterotoxigenic Escherichia coli enhances humoral and CD8+ T cell immunity to a co-administered antigenCell clustering and delay/arrest in T-cell division implicate a novel mechanism of immune modulation by E. coli heat-labile enterotoxin B-subunits.Comparative Adjuvant Effects of Type II Heat-Labile Enterotoxins in Combination with Two Different Candidate Ricin Toxin Vaccine Antigens.LT-IIb(T13I), a non-toxic type II heat-labile enterotoxin, augments the capacity of a ricin toxin subunit vaccine to evoke neutralizing antibodies and protective immunityType II heat-labile enterotoxins: structure, function, and immunomodulatory properties.Enhancement of humoral immunity by the type II heat-labile enterotoxin LT-IIb is dependent upon IL-6 and neutrophils.Adjuvant-Mediated Epitope Specificity and Enhanced Neutralizing Activity of Antibodies Targeting Dengue Virus Envelope Protein
P2860
Q28972540-738FDD6C-7541-4C85-A0A9-D67F8F9A4C2DQ34764532-757C18F5-93A5-4A99-94F8-72DF8432C3CFQ35630112-FEA27E5C-032E-4DF3-8148-DEB5F9EF488CQ36316776-6911CC43-FCC6-49DB-AD53-D96231F5C578Q37066634-D03B5870-C204-4E1F-A6B6-45FB5F66E8DAQ38058640-E2E75CDE-3D5F-4F79-B35C-2FA75407B3BCQ40722407-C04B710D-06AB-49E2-9E97-05C0BBC96D22Q41921198-46CD29AB-5915-4E0B-8DF8-ACB8ED1EF7C7
P2860
Distinctive immunomodulatory and inflammatory properties of the Escherichia coli type II heat-labile enterotoxin LT-IIa and its B pentamer following intradermal administration.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Distinctive immunomodulatory a ...... ng intradermal administration.
@ast
Distinctive immunomodulatory a ...... ng intradermal administration.
@en
type
label
Distinctive immunomodulatory a ...... ng intradermal administration.
@ast
Distinctive immunomodulatory a ...... ng intradermal administration.
@en
prefLabel
Distinctive immunomodulatory a ...... ng intradermal administration.
@ast
Distinctive immunomodulatory a ...... ng intradermal administration.
@en
P2093
P2860
P356
P1476
Distinctive immunomodulatory a ...... ing intradermal administration
@en
P2093
Camila Mathias-Santos
Juliana F Rodrigues
Maria Elisabete Sbrogio-Almeida
Terry D Connell
P2860
P304
P356
10.1128/CVI.00012-11
P577
2011-06-15T00:00:00Z